Vaccine advisers to the US Centers for Disease Control and Prevention argued long and hard Thursday before endorsing giving booster doses of Pfizer's COVID-19 vaccine to people 65 and older, long-term care facility residents and certain people with underlying conditions.
Search / 552 results found Showing: 1-10 of 552
In a highly anticipated announcement, Pfizer said on Monday a Phase 2/3 trial showed its Covid-19 vaccine was safe and generated a "robust" antibody response in children ages 5 to 11.
The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older.
"Unfortunately, we act like the “Dis-United States” rather than the United States..."
Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend emergency use authorization of a booster dose of Pfizer's vaccine six months after full vaccination in people 65 and older and those at high risk of severe COVID-19.
An influential federal advisory panel has soundly rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.
Last December, when advisers to the US Food and Drug Administration met to consider whether the agency should authorize Pfizer's Covid-19 vaccine, it was generally understood that the answer would be yes.
COVID-19 infections have risen "exponentially" among children in the US since July, according to data published Monday by the American Academy of Pediatrics (AAP).
It is a struggle for many of us to get a good night’s sleep, and frequently, taking sleeping pills is the only way people can get some rest.
Health experts predict Pfizer may have a vaccine ready for young children by the end of October, under a best-case scenario.